• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机临床试验中的生成效应修饰因素(GEM's)

Generated effect modifiers (GEM's) in randomized clinical trials.

作者信息

Petkova Eva, Tarpey Thaddeus, Su Zhe, Ogden R Todd

机构信息

Department of Child and Adolescent Psychiatry, New York University, 1 Park Ave., New York, NY 10016, USA and Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA

Department of Mathematics and Statistics, Wright State University, 3640 Colonel Glenn Hwy, Dayton, OH 45435, USA and Department of Child and Adolescent Psychiatry, New York University, 1 Park Ave., New York, NY 10016, USA.

出版信息

Biostatistics. 2017 Jan;18(1):105-118. doi: 10.1093/biostatistics/kxw035. Epub 2016 Jul 27.

DOI:10.1093/biostatistics/kxw035
PMID:27465235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5255046/
Abstract

In a randomized clinical trial (RCT), it is often of interest not only to estimate the effect of various treatments on the outcome, but also to determine whether any patient characteristic has a different relationship with the outcome, depending on treatment. In regression models for the outcome, if there is a non-zero interaction between treatment and a predictor, that predictor is called an "effect modifier". Identification of such effect modifiers is crucial as we move towards precision medicine, that is, optimizing individual treatment assignment based on patient measurements assessed when presenting for treatment. In most settings, there will be several baseline predictor variables that could potentially modify the treatment effects. This article proposes optimal methods of constructing a composite variable (defined as a linear combination of pre-treatment patient characteristics) in order to generate an effect modifier in an RCT setting. Several criteria are considered for generating effect modifiers and their performance is studied via simulations. An example from a RCT is provided for illustration.

摘要

在一项随机临床试验(RCT)中,人们通常不仅感兴趣于估计各种治疗对结局的影响,还想确定是否有任何患者特征根据治疗情况与结局存在不同的关系。在结局的回归模型中,如果治疗与一个预测变量之间存在非零交互作用,那么该预测变量就被称为“效应修饰因素”。随着我们迈向精准医学,即根据治疗时评估的患者测量值优化个体治疗分配,识别此类效应修饰因素至关重要。在大多数情况下,会有几个基线预测变量可能潜在地修饰治疗效果。本文提出了构建复合变量(定义为治疗前患者特征的线性组合)的最优方法,以便在RCT环境中生成一个效应修饰因素。考虑了几种生成效应修饰因素的标准,并通过模拟研究了它们的性能。提供了一个来自RCT的例子用于说明。

相似文献

1
Generated effect modifiers (GEM's) in randomized clinical trials.随机临床试验中的生成效应修饰因素(GEM's)
Biostatistics. 2017 Jan;18(1):105-118. doi: 10.1093/biostatistics/kxw035. Epub 2016 Jul 27.
2
Simple subgroup approximations to optimal treatment regimes from randomized clinical trial data.基于随机临床试验数据的简单亚组近似最优治疗方案
Biostatistics. 2015 Apr;16(2):368-82. doi: 10.1093/biostatistics/kxu049. Epub 2014 Nov 13.
3
The principle of parallelism in the design of studies to estimate treatment effects.估计治疗效果研究设计中的平行原则。
Psychol Methods. 2006 Mar;11(1):1-18. doi: 10.1037/1082-989X.11.1.1.
4
Studying treatment-effect heterogeneity in precision medicine through induced subgroups.通过诱导亚组研究精准医学中的治疗效果异质性。
J Biopharm Stat. 2019;29(3):491-507. doi: 10.1080/10543406.2019.1579220. Epub 2019 Feb 22.
5
On Enrichment Strategies for Biomarker Stratified Clinical Trials.关于生物标志物分层临床试验的富集策略
J Biopharm Stat. 2018;28(2):292-308. doi: 10.1080/10543406.2017.1379532. Epub 2017 Oct 30.
6
Penalized regression procedures for variable selection in the potential outcomes framework.潜在结果框架中用于变量选择的惩罚回归方法。
Stat Med. 2015 May 10;34(10):1645-58. doi: 10.1002/sim.6433. Epub 2015 Jan 28.
7
Improving the relationship between the randomized clinical trial and real-world clinical practice.改善随机临床试验与真实世界临床实践之间的关系。
Psychotherapy (Chic). 2011 Sep;48(3):231-3; discussion 234-6. doi: 10.1037/a0022703.
8
Randomized clinical trial: myths around elementary statistical principles.随机临床试验:围绕基本统计原则的误区
Onkologie. 2003 Dec;26(6):551-6. doi: 10.1159/000074150.
9
Why caution is recommended with post-hoc individual patient matching for estimation of treatment effect in parallel-group randomized controlled trials: the case of acute stroke trials.为何在平行组随机对照试验中进行事后个体患者匹配以估计治疗效果时建议谨慎:急性中风试验的案例
Stat Med. 2013 Nov 10;32(25):4467-81. doi: 10.1002/sim.5862. Epub 2013 Jun 12.
10
Enhanced precision in the analysis of randomized trials with ordinal outcomes.对具有有序结局的随机试验进行分析时提高精度。
Biometrics. 2016 Jun;72(2):422-31. doi: 10.1111/biom.12450. Epub 2015 Nov 17.

引用本文的文献

1
A Bayesian multivariate hierarchical model for developing a treatment benefit index using mixed types of outcomes.利用混合类型结局构建治疗获益指数的贝叶斯多元层次模型。
BMC Med Res Methodol. 2024 Sep 27;24(1):218. doi: 10.1186/s12874-024-02333-z.
2
A Single Index Model for Longitudinal Outcomes to Optimize Individual Treatment Decision Rules.一种用于纵向结果以优化个体治疗决策规则的单指标模型。
Stat. 2022 Dec;11(1). doi: 10.1002/sta4.493. Epub 2022 Aug 8.
3
Improving Individualized Treatment Decisions: A Bayesian Multivariate Hierarchical Model for Developing a Treatment Benefit Index using Mixed Types of Outcomes.改善个性化治疗决策:一种使用混合类型结果开发治疗效益指数的贝叶斯多变量层次模型
medRxiv. 2024 Jan 7:2023.11.17.23298711. doi: 10.1101/2023.11.17.23298711.
4
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.治疗获益指数的制定与验证:识别可能从恢复期血浆治疗中获益的 COVID-19 住院患者
JAMA Netw Open. 2022 Jan 4;5(1):e2147375. doi: 10.1001/jamanetworkopen.2021.47375.
5
The concept of justifiable healthcare and how big data can help us to achieve it.有理由的医疗保健的概念,以及大数据如何帮助我们实现这一目标。
BMC Med Inform Decis Mak. 2021 Mar 6;21(1):87. doi: 10.1186/s12911-021-01444-7.
6
Predictive approaches to heterogeneous treatment effects: a scoping review.预测异质治疗效果的方法:范围综述。
BMC Med Res Methodol. 2020 Oct 23;20(1):264. doi: 10.1186/s12874-020-01145-1.
7
A single-index model with multiple-links.具有多重链接的单指数模型。
J Stat Plan Inference. 2020 Mar;205:115-128. doi: 10.1016/j.jspi.2019.05.008. Epub 2019 Jul 4.
8
Predicting Depression Symptoms in Families at Risk for Depression: Interrelations of Posterior EEG Alpha and Religion/Spirituality.预测有抑郁风险的家庭中的抑郁症状:后 EEGα与宗教/灵性的相互关系。
J Affect Disord. 2020 Sep 1;274:969-976. doi: 10.1016/j.jad.2020.05.084. Epub 2020 May 27.
9
Optimising treatment decision rules through generated effect modifiers: a precision medicine tutorial.通过生成效应修饰符优化治疗决策规则:精准医学教程
BJPsych Open. 2019 Dec 3;6(1):e2. doi: 10.1192/bjo.2019.85.
10
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.预测治疗效果异质性的方法(PATH)声明:解释和说明。
Ann Intern Med. 2020 Jan 7;172(1):W1-W25. doi: 10.7326/M18-3668. Epub 2019 Nov 12.

本文引用的文献

1
Tree-based methods for individualized treatment regimes.用于个性化治疗方案的基于树的方法。
Biometrika. 2015;102(3):501-514. doi: 10.1093/biomet/asv028. Epub 2015 Jul 15.
2
New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.用于估计最优动态治疗方案的新统计学习方法。
J Am Stat Assoc. 2015;110(510):583-598. doi: 10.1080/01621459.2014.937488.
3
Treatment decisions based on scalar and functional baseline covariates.基于标量和功能基线协变量的治疗决策。
Biometrics. 2015 Dec;71(4):884-94. doi: 10.1111/biom.12346. Epub 2015 Jun 25.
4
On Sparse representation for Optimal Individualized Treatment Selection with Penalized Outcome Weighted Learning.基于惩罚性结果加权学习的最优个体化治疗选择的稀疏表示
Stat. 2015;4(1):59-68. doi: 10.1002/sta4.78.
5
Detecting treatment-covariate interactions using permutation methods.使用置换法检测治疗协变量相互作用。
Stat Med. 2015 May 30;34(12):2035-47. doi: 10.1002/sim.6457. Epub 2015 Mar 2.
6
Estimation of treatment policies based on functional predictors.基于功能预测器的治疗策略估计
Stat Sin. 2014 Jul;24(3):1461-1485. doi: 10.5705/ss.2012.196.
7
Combining biomarkers to optimize patient treatment recommendations.结合生物标志物以优化患者治疗建议。
Biometrics. 2014 Sep;70(3):695-707. doi: 10.1111/biom.12191. Epub 2014 May 30.
8
Estimating Optimal Treatment Regimes from a Classification Perspective.从分类角度估计最优治疗方案。
Stat. 2012 Jan 1;1(1):103-114. doi: 10.1002/sta.411.
9
Estimating Individualized Treatment Rules Using Outcome Weighted Learning.使用结果加权学习估计个体化治疗规则。
J Am Stat Assoc. 2012 Sep 1;107(449):1106-1118. doi: 10.1080/01621459.2012.695674.
10
Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.发现、比较和综合随机临床试验后治疗结果的调节因素:一种参数方法。
Stat Med. 2013 May 20;32(11):1964-73. doi: 10.1002/sim.5734. Epub 2013 Jan 10.